June 1 2023: Acclarogen publishes with AstraZeneca, UK
Hughes R, Rapsomaniki E, Bansal AT, Vestbo J, Price D, Agusti A, Beasley R, Fageras M, Alacqua M, Papi A, Mullerova H, Reddel HK. Cluster analyses from the real-world NOVELTY study: six clusters across the asthma-COPD spectrum. J Allergy Clin Immunol Pract.
May 30 2023: Acclarogen publishes with the University of Bath, UK
Ainsworth A, Chatburn E, Bansal AT, Fulton O, Hamerlijnck D, Coleman C, Eger K, Hyland M, Holmes J, Heaney L, Sedlak V, Skrgat S, Elelbaher N, ten Brinke A, Porsbjerg C, Gaga M, Loureiro C, Djukanovic R, Berret E, Kwon N. What bothers severe asthma patients most? A paired patient-clinician study across seven European countries. ERJ Open Research.
May 10 2023: Acclarogen publishes with Amsterdam University Medical Centre, NL
Abdel-Aziz MI, Thorsen J, Hashimoto S, Vijverberg SJH, Neerincx AH, Brinkman P, van Aalderen W, Stokholm J, Rasmussen MA, Roggenbuck-Wedemeyer M, Vissing NH, Mortensen MS, Brejnrod AD, Fleming LJ, Murray CS, Fowler SJ, Frey U, Bush A, Singer F, Hedlin G, Nordlund B, Shaw DE, Chung KF, Adcock IM, Djukanovic R, Auffray C, Bansal AT, Sousa AR, Wagers SS, Chawes BL, Bønnelykke K, Sørensen SJ, Kraneveld AD, Sterk PJ, Roberts G, Bisgaard H, Maitland-van der Zee AH, on behalf of the U-BIOPRED Study Group. Oropharyngeal microbiota clusters in children with asthma/wheeze associated with allergy, blood transcriptomic immune pathways and exacerbations risk. Am J Crit Care Med.
April 3 2023: Acclarogen publishes with the European Respiratory Society's SHARP CRC
Kroes JA, Alfonso-Christancho R, Bansal AT, Berret E, Bieksiene K, Bourdin A, Brussino L, Canhoto D, Cardini C, Celik G, Csoma Z, Dahlen B, Damadoglu E, Eger K, Gauquelin L, Gemicioglu B, Goksel O, Graff S, Heffler E, Hofstee HB, Howarth P, Jakes R, Jaun F, Kalinauskaite-Zukauske V, Kopac P, Kwon N, Loureiro CC, Lozoya Garcia V, Masoli M, Paula Rezelj M, Perez de Llano L, Popovic-Grle S, Ramos-Barbon d, sa Sousa A, Samitas K, Schleich F, Sirena C, Skrgat S, Zervas E, Zichnalis G, Bel EH, Sont JK, Hashimoto S, ten Brinke A. Evaluation of real-world mepolizumab in severe asthma across Europe – the SHARP experience with privacy-preserving federated analysis. ERJ Open Res.
March 12 2023: Acclarogen publishes with the University of Southampton, UK
Brandsma J, Schofield JPR, Yang X, Strazzeri F, Barber C, Goss VM, Koster G, Bakke PS, Caruso M, Chanez P, Dahlen SE, Fowler SJ, Horvath I, Howarth PH, Krug N, Montuschi P, Sanak M, Sandstrom T, Shaw DE, Chung KF, Singer F, Fleming LJ, Adcock IM, Pandis I, Bansal AT, Corfield J, Sousa AR, Sterk PJ, Roberts G, Sanchez Garcia R, Skipp PJ, Postle AD, Djukanovic R, on behalf of the U-BIOPRED Study Group. Stratification of asthma by lipidomic profiling of induced sputum supernatant. J Allergy Clin Immunol.
January 4 2023: Acclarogen publishes with Global Genomics Group, USA
Voros S, Bansal AT, Barnes MR, Narula J, Maurovich-Horvat P, Vazquez G, Marvasty IB, Brown BO, Voros ID, Harris W, Voros V, Dayspring T, Neff D, Greenfield A, Furchtgott L, Church B, Runge K, Khalil I, Hayete B, Lugero D, Remaley AT, Newton RS. Bayesian network analysis of panomic biological big data identifies the importance of triglyceride-rich LDL in atherosclerosis development. Front Cardiovasc Med.
October 6 2022: Acclarogen publishes with Leiden University Medical Centre, Netherlands
Kroes JA, Bansal AT, Berret E, Christian N, Kremer A, Alloni A, Gabetta M, Marshall C, Wagers S, Djukanovic R, Porsbjerg C, Hamerlijnck, Fulton O, ten Brinke A, Bel EH, Sont JK. Blueprint for harmonising non-standardised disease registries to allow federated data analysis – prepare for the future. ERJ Open Research.
July 29 2022: Acclarogen publishes with the University of Copenhagen, Denmark
Thorsen J, Stokholm J, Rasmussen MA, Roggenbuch-Wedemeyer M, Vissing NH, Mortensen MS, Brejnrod AD, Fleming L, Bush A, Roberts G, Singer F, Frey U, Hedlin G, Nordlund B, Murray C, Abdel-Aziz MI, Hashimoto S, van Aalderen W, Maitland-van der Zee AH, Shaw D, Fowler SJ, Sousa A, Sterk PJ, Chung KF, Adcock IM, Djukanovic R, Auffray C, Bansal AT, Wagers S, Chawes B, Bonnelykke K, Sorensen SJ, Bisgaard H. Asthma and wheeze severity and the oropharyngeal microbiota in children and adolescents. Ann Am Thorac Soc [Epub ahead of print].
April 28 2022: Acclarogen publishes with NHLI, Imperial College London, UK
Hoda U, Pavlidis S, Bansal AT, Takahashi K, Hu S, Kwong FNK, Rossios C, Sun K, Bhavsar P, Loza M, Baribaud F, Chanez P, Fowler SJ, Horvath I, Montuschi P, Singer F, Musial J, Dahlen B, Krug N, Sandstrom T, Shaw DE, Lutter R, Fleming LJ, Howarth PH, Caruso M, Sousa AR, Corfield J, Auffray C, de Meulder B, Lefaudeux D, Dahlen Djukanovic R, Sterk PJ, Guo Y, Adcock IM, Chung KF, U-BIOPRED study group. Clinical and transcriptomic features of persistent exacerbation-prone severe asthma in U-BIOPRED cohort. Clin Transl Med [Epub ahead of print].
December 10 2021: Acclarogen publishes with NHLBI, NIH, Bethesda, USA
Lucero D, Dikilitas O, Mendelson MM, Aligabi Z, Islam P, Neufeld EB, Bansal AT, Freeman LA, Vaisman B, Tang J, Combs CA, Li Y, Voros S, Kullo IJ, Remaley A. Transgelin: A new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screen. J Lipid Res [Epub ahead of print].
November 25 2021: Acclarogen publishes with Amsterdam University Medical Centre, NL
Abdel-Aziz MI, Vijverberg SJH, Neerincx AH, Brinkman P, Wagener AH, Riley JH, Sousa AR, Bates S, Wagers SS, de Meulder B, Auffray C, Wheelock A, Bansal AT, Caruso M, Chanez P, Uddin M, Corfield J, Horvath I, Krug N, Musial J, Sun K, Shaw DE, Sandström T, Montuschi P, Fowler SJ, Lutter R, Djukanovic R, Howarth P, Skipp P, Sanak M, Adcock IM, Chung KF, Sterk PJ, Kraneveld AD, Maitland-van der Zee AH, U-BIOPRED Study Group. A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes. Eur Respir J [Epub ahead of print].
February 25 2021: Acclarogen publishes with AstraZeneca, UK
Reddel HK, Vestbo J, Agusti A, Anderson GP, Bansal AT, Beasley R, Bel EH, Janson C, Make B, Pavord ID, Price D, Rapsomaniki E, Karlsson N, Finch D, Nuevo J, de Giorgio Miller A, Alacqua M, Hughes R, Mullerova H, Gerhardsson de Verdier M, for the NOVELTY study investigators. Heterogeneity within and between physician-diagnosed asthma and/ or COPD: NOVELTY cohort. Eur Respir J [Epub ahead of print].
February 19 2021: Acclarogen publishes with the University of Manchester, UK
Alahmadi FH, Simpson AJ, Gomez C, Ericsson M, Thorngren J-O, Wheelock C, Bates S, Knowles R, Sun K, Horvath I, Sterk PJ, Fowler S, Dahlen SE, Shaw DE, Fleming LJ, Roberts G, Riley J, Sousa AR, Bansal AT, Corfield J, Pandis I, Sanchez M, Caruso M, Chanez P, Dahlen B, Krug N, Montuschi P, Singer F, Wagers S, Adcock IM, Djukanovic R, Chung KF on behalf of the U-BIOPRED Study Group. Medication adherence in patients prescribed oral corticosteroids in the U-BIOPRED cohort. CHEST [Epub ahead of print].
May 18 2020: Acclarogen publishes with GlaxoSmithKline, UK
Kwon N, Pizzichini E, Bansal AT, Albers FC, Barnes N, Riley JH, Lima-Matos A, Ponte EV, Cruz AA. Factors that affect blood eosinophil counts in a non-asthmatic population: post hoc analysis of data from Brazil. World Allergy Organisation [Epub ahead of print].
November 26 2019: Acclarogen publishes with the Federal University of Bahia, Brazil
Cruz AA, Riley JH, Bansal AT, Ponte EV, Souza-Machado A, Almeida PC, Biao-Lima V, Davis M, Bates S, Adcock IM, Sterk PJ, Chung KF, the ProAR Study Group, the U-BIOPRED Study Group (2019). Asthma similarities across ProAR (Brazil) and U-BIOPRED (Europe) adult cohorts of contrasting locations, ethnicity and socioeconomic status. Respir Med [Epub ahead of print].
April 25 2019: Acclarogen publishes with the University of Southampton, UK
Perotin JM, Schofield JPR, Wilson S, Ward J, Brandsma J, Strazzeri F, Bansal AT, Xian Y, Rowe A, Corfield J, Lutter R, Shaw DE, Bakke PS, Caruso M, Dahlen B, Fowler SJ, Horvath I, Howarth P, Krug N, Montuschi P, Sanak M, Sandstrom T, Sun K, Pandis I, Auffray C, de Meulder B, Lefaudeux D, Riley JR, Sousa AR, Dahlen SE, Adcock I, Chung KF, Sterk PJ, Skipp PJ, Collins JE, Davies DE, Djukanovic R, on behalf of the U-BIOPRED Study Group (2019). Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux. Eur Respir J [Epub ahead of print].
April 10 2019: Acclarogen publishes with Roche Products, UK
Wei L, Pavlovic V, Bansal AT, Chen X, Foster GR, He H, Kao JH, Lampertico P, Liaw Y-F, Motoc A, Papatheodoridis GV, Piratvisuth T, Plesniak R, Wat C (2019). Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B. J Viral Hepat [Epub ahead of print].
March 28 2019: Acclarogen publishes with the University of Southampton, UK
Schofield JPR, Burg D, Nicholas B, Strazzeri F, Brandsma J, Staykova D, Folisi C, Bansal AT, Xian Y, Guo Y, Rowe AR, Corfield J, Wilson S, Ward J, Lutter R, Shaw DE, Bakke PS, Caruso M, Dahlen SE, Fowlder SJ, Horvath I, Howarth P, Krug N, Montuschi P, Sanak M, Sandstrom T, Sun K, Pandis I, Riley JR, Auffray C, de Meulder B, Lefaudeux D, Sousa AR, Adcock IM, Chung KF, Sterk PJ Skipp PJ, Djukanovic R, on behalf of the U-BIOPRED Study Group (2019). Stratification of asthma phenotypes by airway proteomic signatures. J Allergy Clin Immunol [Epub ahead of print].
February 11 2019: Acclarogen publishes with the University of Southampton, UK
Tariq K, Schofield JPR, Nicholas B, Burg D, Brandsma J, Bansal AT, Wilson S, Lutter R, Fowler SJ, Bakke PS, Caruso M, Dahlen S, Horvath I, Krug N, Montuschi P, Sanak M, Sandstrom T, Geiser T, Pandis I, Sousa AR, Adcock IM, Shaw DE, Auffray C, Howarth PH, Sterk PJ, Chunk KF, Skipp P, Dimitrov B, Djukanovic R and the U-BIOPRED Study Group (2019). Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma. Respir Med [Epub ahead of print].
February 6 2019: Acclarogen publishes with AstraZeneca, UK
Reddel HK, Gerhardsson de Verdier M, Agusti A, Anderson G, Beasley R, Bel EH, Janson C, Make B, Martin RJ, Pavord I, Price D, Keen C, Gardev A, Rennard S, Svereus A, Bansal AT, Brannman L, Karlsson N, Nuevo J, Nyberg F, Young S, Vestbo J (2019). A NOVEL observational longiTudinal study in patients with obstructive lung disease: study design. ERJ Open Research 2019 5:00036-2018 [https://doi.org/10.1183/23120541.00036-2018].
December 5 2018: Acclarogen publishes with Amsterdam University Medical Centre, NL
Brinkman P, Wagener AH, Hekking PP, Bansal AT, SMatiland-van der Zee AH, Wang Y, Weda H, Knobel HH, Vink TJ, Rattray NJ, D’Amico A, Pennazza G, Santonico M, Lefaudeux D, de Meulder B, Auffray C, Bakke PS, Caruso M, Chanez P, Chung KF, Corfield J, Dahlen SE, Djukanovic R, Geiser T, Horvath I, Krug N, Musial J, Sun K, Riley JH, Shaw DE, Sandstrom T, Sousa AR, Montuschi P, Fowler SJ, Sterk PJ, and the U-BIOPRED Study Group (2018). Identification and prospective stability of eNose derived phenotypes in severe asthma. J Allergy Clin Immunol [Epub ahead of print]
October 11 2018: Acclarogen publishes with the University of Manchester, UK
Simpson AJ, Hekking PP, Shaw DE, Fleming LJ, Roberts G, Riley JR, Bates S, Sousa AR, Bansal AT, Pandis I, Sun K, Bakke PS, Caruso M, Dahlen B, Dahlen SE, Horvath I, Krug N, Montuschi P, Sandstrom T, Singer F, Adcock IM, Wagers S, Djukanovic R, Chung KF, Sterk PJ, Fowler SJ, U-BIOPRED Study Group (2018). Treatable Traits in the European U-BIOPRED Adult Asthma Cohorts. Allergy [Epub ahead of print].
September 25 2018: Acclarogen publishes with the University of Southampton, UK
Brandsma J, Goss VM, Yang X, Bakke PS, Caruso M, Chanez P, Dahlen SE, Fowler SJ, Horvath I, Krug N, Montuschi P, Sanak M, Sandstrom T, Shaw DE, Chung KF, Singer F, Fleming LJ, Sousa AR, Pandis I, Bansal AT, Sterk PJ, Djukanovic R, Postle AD, The U-BIOPRED Study Group (2018). Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers. Metabolomics 14: 123.
September 21 s018: Acclarogen publishes with the University of Catania, Italy
Emma R, Bansal AT, Kolmert J, Wheelock CE, Dahlen SE, Loza MJ, De Meulder B, Lefaudeux D, Auffray C, Dahlen B, Bakke PS, Chanez P, Fowler SJ, Horvath I, Montuschi P, Krug N, Sanak M, Sandstrom T, Shaw DE, Fleming LJ, Djukanovic R, Howarth PH, Singer F, Sousa AR, Sterk PJ, Corfield J, Pandis I, Chung KF, Adcock IM, Lutter R, Fabbella L, Caruso M, on behalf of the U-BIOPRED Study Group (2018). Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort. PLoS One 13(9): e0203874.
June 1 2018: Acclarogen publishes with the University of Southampton, UK
Burg D, Schofield JPR, Brandsma J, Staykova D, Folisi, C, Bansal A, Nicholad B, Xian Y, Rowe A, Corfield J, Wilson S, Ward J, Lutter R, Fleming L, Shaw DE, Bakke PS, Caruso M, Dahlen SE, Fowler SJ, Hashimoto S, Horvath I, Howarth P, Krug N, Montuschi P, Sanak M, Sandstrom T, Singer F, Sun K, Pandis I, Auffray C, Sousa AR, Adcock IM, Chung KF, Sterk PJ, Djukanovic R, Skipp PJ, the U-BIOPRED study group (2018). Large-scale label-free quantitative mapping of the sputum proteome. J Proteome Res 17(6):2072-2091.
May 30 2018: Acclarogen publishes with the EISBM, Belgium
deMeulder B, Lefaudeux D, Bansal AT, Mazein A, Chaibonchoes A, Ahmed H, Balaur I, Saqi M, Pellet J, Ballereau S, Lemmonier N, Sun K, Pandie I, Yang X, Batuwitage M, Kretsos K, van Eyll J, Bedding A, Davison T, Dodson P, Larminie C, Postle A, Corfield J, Djukanovic R, Chung KF, Adcock IM, Guo YK, Sterk PJ, Manta A, Rowe A, Baribaud F, Auffray C and the U-BIOPRED Study Group and the eTRIKS Consortium (2018). A computational framework for complex disease stratification from multiple large-scale datasets. BMC Systems Biology 12:60.
November 9 2017: Neil Fitch joins Acclarogen
Acclarogen is delighted to announce the appointment of Neil Fitch to the team. Neil will lead the development of new business opportunities, with a specific focus on accessible archiving, a new product that complements the specialist consultancy services offered by Acclarogen.
September 27 2017: Acclarogen publishes with Amsterdam University Medical Centre, NL
Hekking PP, Loza MJ, Pavlidis S, de Meulder B, Lefaudeux D, Baribaud F, Auffray C, Wagener AH, Brinkman P, Lutter R, Bansal AT, Sousa AR, Bates S, Pandis Y, Fleming LJ, Shaw DE, Fowler SJ, Guo Y, Meiser A, Sun K, Corfield J, Howarth P, Bel EH, Adcock IM, Chung KF, Djukanovic R, Sterk PJ and the U-BIOPRED Study Group (2017). Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma. Eur Respir J 50(3): 1602298.
July 26 2017: Acclarogen publishes with Amsterdam University Medical Centre, NL
Hekking PP, Loza MJ, Pavlidis S, de Meulder B, Lefaudeux D, Baribaud F, Auffray C, Wagener AH, Brinkman P, Lutter I, Bansal AT, Sousa AR, Bates S, Pandis Y, Fleming LJ, Shaw DE, Fowler SJ, Guo Y, Meiser A, Sun K, Corfield J, Howarth P, Bel EH, Adcock IM, Chung KF, Djukanovic R, Sterk PJ and the U-BIOPRED Study Group (2017). Pathway discovery using transcriptomic profiles in adult-onset severe asthma. J Allergy Clin Immunol [Epub ahead of print].
May 18 2017: Acclarogen publishes with Imperial College London, UK
Rossios C, Pavlidis S, Hoda U, Kuo CH, Loza M, Baribaud F, Durham AL, Ojo O, Lutter R, Rowe A, Bansal A, Auffray C, Sousa A, Corfield J, Djukanovic R, Guo Y, Sterk PJ, Adcock IM, Chung KF on behalf of the UBIOPRED consortia project team (2017). Sputum transcriptomics reveal up-regulation of IL-1 receptor family members in severe asthma J Allergy Clin Immunol [Epub ahead of print].
October 20 2016: Acclarogen Publishes with the Pan-European U-BIOPRED Consortium
Lefaudeux D, De Meulder B, Loza MJ, Peffer N, Rowe A, Baribaud F, Bansal AT, Lutter R, Sousa AR, Corfield J, Pandis I, Bakke PS, Caruso M, Chanez P, Dahlen SE, Fleming LJ, Fowler SJ, Horvath I, Krug N, Montuschi P,Sanek M, Sandstrom T, Shaw DE, Singer F, Sterk PJ, Roberts G, Adcock IM, Djukanovic R, Auffray C, Chung KF and the U-BIOPRED Study Group (2016). U-BIOPRED clinical adult asthma clusters linked to a subset of sputum ‘omics. J Allergy Clin Immunol [Epub ahead of print].
October 6 2016: Acclarogen publishes with the University of Southampton, UK
Wilson SJ, Ward JA, Sousa AR, Corfield J, Bansal AT, de Meulder B, Lefaudeux D, Auffray C, Loza M, Baribaud F, Fitch, N, Sterk PJ, Chung KF, Gibeon D, Adcock I, Djukanovic R, Dahlen B, Chanez P, Shaw D, Krug N, Hohlfeld J, Sandstrom T, Howarth PH on behalf of the U-BIOPRED Consortium (2016). Severe asthma exists despite suppressed tissue inflammation within the proximal airways: findings from the U-BIOPRED bronchoscopy sub-cohort. Eur Respir J 48:1307-1319.
May 31 2016: Acclarogen publishes with Crescent Diagnostics, UK
Beattie JR, Cummins NM, Caraher C, O’Driscoll OM, Bansal AT, Eastell R, Ralson SH, Stone MD, Pearson G, Towler MR (2016). Raman spectroscopic analysis of fingernail clippings can help differentiate between post-menopausal women who have and have not suffered a fracture. Clin Med Insights Arthritis Musculoskelet Disord 9:109-16.
November 16 2015: Liling Warren Joins Acclarogen
Acclarogen is delighted to announce the appointment of Liling Warren PhD. as US-based consultant biostatistician. Liling brings a wealth of relevant experience gained at GlaxoSmithKline and in biotech. Her deep knowledge and easy rapport will help us to bolster our already-strong working relationships with US-based companies.
September 24 2015: Acclarogen publishes with the U-BIOPRED Consortium
Fleming LJ, Murray C, Bansal AT, Hashimoto S, Bisgaard H, Bush A, Frey R, Hedlin G, Singer F, van Aalderen WM, et al on behalf of the U-BIOPRED Consortium (2015). The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts. Eur Respir J [Epub ahead of print].
Shaw DE, Sousa AR, Fowler S, Fleming LJ, Roberts G, Corfield J, Pandis I, Bansal AT , Bel E, Auffray C et al, on behalf of the U-BIOPRED Consortium (2015). Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J [Epub ahead of print].
Shaw DE, Sousa AR, Fowler S, Fleming LJ, Roberts G, Corfield J, Pandis I, Bansal AT , Bel E, Auffray C et al, on behalf of the U-BIOPRED Consortium (2015). Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J [Epub ahead of print].
June 1 2015: Kristina Lane to Lead Data Management for Acclarogen
Acclarogen is delighted to announce the appointment of Kris Lane as Head of Data Management at Acclarogen. It is a formalisation of a longer-standing relationship: Kris has already proved her tenacity and eye for detail by leading the rapid digitisation of the U-BIOPRED longitudinal questionnaires.
December 17 2014: Acclarogen publishes with Global Genomics Group, USA
Voros S, Maurovich-Horvat P, Marvasty IB, Bansal AT, Barnes MR, Vazquez G, Murray SS, Voros V,Merkely B, Brown BO, Warnick GR (2014). Precision phenotyping, panomics and systems-level bioinformatics to delineate complex biologies of atherosclerosis: Rationale and Design of the "Genetic Loci and the Burden of Atherosclerotic Lesions" ("GLOBAL") Study. J Cardiovasc Comput Tomogr 8(6): 442-51.
October 17 2014: Acclarogen publishes with Hoffman-La Roche, Switzerland
Lambrechts D, Moisse M, Delmar P, Miles DW, Leighl N, Escudier B, van Cutsem E, Bansal AT, Carmeliet P, Scherer SJ, de Haas S, Pallaud C (2014). Genetic markers of bevacizumab-induced hypertension. Angiogenesis 17(3): 685-694
de Haas S, Delmar P, Bansal AT, Moisse M, Miles DW, Leighl N, Escudier B, van Cutsem E, Carmeliet P, Scherer SJ, Pallaud C, Lambrechts D (2014). Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy. Angiogenesis 17(4):909-20.
de Haas S, Delmar P, Bansal AT, Moisse M, Miles DW, Leighl N, Escudier B, van Cutsem E, Carmeliet P, Scherer SJ, Pallaud C, Lambrechts D (2014). Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy. Angiogenesis 17(4):909-20.
September 27 2013: Acclarogen publishes with Sequenom Inc., USA
Perlee LT, Bansal AT, Gehrs K, Heier JS, Csaky K, Allikmets R, Oeth P, Paladino T, Farkas DH, Rawlings PL, Hageman GS (2013). Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy. Opthalmology 120(9): 1880-92.
July 26 2013: Acclarogen publishes with King's College London, UK
Williams FMK, Bansal AT*, van Meurs JB*, Bell JT, Meulenbelt I, Suri P, Rivadeneira F, Sambrook PN, Hofman A, Bierma-Zeinstra S, Menni C, Kloppenburg M, Slagboom PE, Hunter DJ, MacGregor AJ, Uitterlinden AG, Spector TD (2013). Novel genetic variants associated with lumbar disc degeneration in northern Europeans: a meta-analysis of 4,600 subjects. Annals Rheum Dis 72(7): 1141-8.
June 28 2013: Acclarogen publishes with Roche Products, UK
Wang J*, Bansal AT*, Martin M, Germer S, Benayed R, Essioux L, Lee JS, Begovich A, Hemmings A, Kenwright A, Taylor KE, Upmanyu R, Cutler P, Harari O, Gregerson PK, Marchini J, Criswell LA, Platt A (2013) . Genome-wide association analysis implicates the involvement of 8 loci with response to tocilizumab for the treatment of rheumatoid arthritis. Pharmacogenomics J 13(3): 235-41.
May 31 2013: Acclarogen publishes with the International VISIGEN Consortium
Keating B*, Bansal AT*, Walsh S, Millman J, Newman J, Kidd K, Budowle B, Eisenberg A, Donfack J, Gasparini P, Budimlija Z, Henders AK, Chandrupatla H, Duffy DL, Gordon SD, Hysi P, Liu F, Medland SE, Rubin L, Martin NG, Spector TD, Kayser M (2013). First all-in-one diagnostic tool for DNA intelligence: genome-wide inference of bio-geographic ancestry, appearance, relatedness and sex with the Identitas v1 Forensic Chip. Int J Legal Med 127: 559-572.